Calamos Advisors LLC Jazz Pharmaceuticals PLC Transaction History

Calamos Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$133.98 - $160.47 $73,153 - $87,616	-546 Reduced 1.23%	43,770 $6.4 Million
Q4 2022 Jan 25, 2023	BUY	$129.72 - $159.85 $23,219 - $28,613	179 Added 0.41%	44,316 $0
Q3 2022 Oct 24, 2022	BUY	$126.59 - $161.18 $16,076 - $20,469	127 Added 0.29%	44,137 $5.88 Million
Q2 2022 Aug 01, 2022	SELL	$141.59 - $168.66 $130,970 - $156,010	-925 Reduced 2.06%	44,010 $6.87 Million
Q1 2022 May 03, 2022	BUY	$129.64 - $160.7 $5.83 Million - $7.22 Million	44,935 New	44,935 $7 Million
Q3 2021 Oct 26, 2021	SELL	$128.64 - $184.79 $2.18 Million - $3.13 Million	-16,940 Closed	0 $0
Q2 2021 Jul 22, 2021	BUY	$160.2 - $186.42 $2.71 Million - $3.16 Million	16,940 New	16,940 $3.01 Million

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.7B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Calamos Advisors LLC with notifications on news.